329 related articles for article (PubMed ID: 22482828)
1. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
2. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
[TBL] [Abstract][Full Text] [Related]
4. Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients.
Molinier O; Goupil F; Debieuvre D; Auliac JB; Jeandeau S; Lacroix S; Martin F; Grivaux M
Respir Med Res; 2020 Mar; 77():46-54. PubMed ID: 32036284
[TBL] [Abstract][Full Text] [Related]
5. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.
Prince S; Zeidman A; Dekel Y; Ram E; Koren R
Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265
[TBL] [Abstract][Full Text] [Related]
8. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
9. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
[TBL] [Abstract][Full Text] [Related]
11. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.
Qu Y; Emoto K; Eguchi T; Aly RG; Zheng H; Chaft JE; Tan KS; Jones DR; Kris MG; Adusumilli PS; Travis WD
J Thorac Oncol; 2019 Mar; 14(3):482-493. PubMed ID: 30503889
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
15. Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.
Kobayashi H; Minami Y; Anami Y; Kondou Y; Iijima T; Kano J; Morishita Y; Tsuta K; Hayashi S; Noguchi M
Virchows Arch; 2010 Jul; 457(1):69-76. PubMed ID: 20473768
[TBL] [Abstract][Full Text] [Related]
16. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
[TBL] [Abstract][Full Text] [Related]
17. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
[TBL] [Abstract][Full Text] [Related]
18. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
[TBL] [Abstract][Full Text] [Related]
19. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of EpCAM and Trop2 in pituitary adenomas.
Chen X; Pang B; Liang Y; Xu SC; Xin T; Fan HT; Yu YB; Pang Q
Int J Clin Exp Pathol; 2014; 7(11):7907-14. PubMed ID: 25550831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]